Minireviews
Copyright ©The Author(s) 2021.
World J Meta-Anal. Jun 28, 2021; 9(3): 286-296
Published online Jun 28, 2021. doi: 10.13105/wjma.v9.i3.286
Table 1 Clinical presentation of the patients with acute myocarditis

Clinical presentation of acute myocarditis
1No clinical manifestations
2Abnormal ECG or X-ray
3Unexplained sinus tachycardia
4Atrial or ventricular premature beats
5Atrial or ventricular tachycardia
6Partial or complete heart block
7Ventricular fibrillation/cardiac arrest
8Acute cardiac failure
9Circulatory collapse (shock)
Table 2 Incidence and clinical manifestations of dengue viral infections with cardiac involvement
Ref.
Diagnosis
Study population
Incidence, %
Cardiac assessment methods
Main findings and clinical outcomes
Wali et al[24], 1998DHF/DSS17 (14-58 yr)70.59ECG. ECHO. Radionuclide ventriculography. Tc-99m pyrophosphate imagingECG showed ST and T wave changes (29.4%). Mean LVEF = 41.7%. Mean LVEF in DSS patients = 39.63%
Kabra et al[25], 1998DF/DHF/DSS 54 (< 12 yr) 16.70 ECHO LVEF < 50% in 16.7% of patients. LVEF < 35% in 3.7% of patients. Repeat ECHO after 2 mo showed improved LVEF
Khongphatthanayothin et al[26], 2003DHF24 (10.8 ± 2.8 yr)-ECHO (VCFC/ESS)Lower LVEF, VCFC/ESS, CI, EDV and higher SVR during critical phase vs recovery phase
Kularatne et al[27], 2007DF 120 (13-76 yr) 62.50 ECG. Cardiac markersECG abnormalities: (1) Sinus bradycardia; (2) ST-segment changes; (3) T wave changes; and (4) Right bundle branch block in 62.5% of patients; increased troponin levels in 29.4% of 17 patients
Khongphatthanayothin et al[28], 2007DF/DHF/DSS91 (5-15 yr)17.58ECHO. Cardiac markersReduced LVEF (< 50%) was found in 6.7%, 13.8%, and 36% of patients with DF, DHF, and DSS during the critical phase, respectively. No abnormal cardiac markers
Salgado et al[29], 2009DF/DHF 102 (13 mo-10 yr) 10.70 ECG. ECHO ECG: (1) Sinus bradycardia in 81.8% of 11 patients; and (2) Tachycardia in 18.2% of 11 patients, and T wave inversion in seven of 11 patients. ECHO: Pericardial effusions in 71.4% of 7 patients
La-Orkhun et al[30], 2011DF/DHF/DSS35 (5-15 yr)29.00ECG, 24-h Holter monitoringDuring recovery phase: (1) Sinus arrhythmias; (2) First-degree AV block; (3) Mobitz type I second-degree AV block; (4) Atrial ectopic beats; and (5) Ventricular ectopic beats
Yacoub et al[18], 2012DF/DHF/DSS 79 (8-46 yr) 35.00 ECG. ECHO. Cardiac markers Abnormal ECG: (1) Sinus arrhythmias; (2) First-degree AV block; (3) T-wave changes; and (4) ST segment abnormalities. Systolic impairment in 45% of patients, diastolic impairment in 42%. Septal and right ventricular walls predominantly affected, worse in severe cases. 1 patient had elevated troponin I
Miranda et al[31], 2013DF/DHF/DSS81 (4 mo-81 yr)14.81Cardiac markers (troponin I and NTproBNP). ECHO. ECG. CMRElevated troponin I and/or NTproBNP in 14.81% of patients. 4/10 of patients had abnormal ECHO: (1) Functional abnormalities; and (2) Regional wall abnormalities. 4 patients had myocardial enhancement by CMR
Sengupta et al[32], 2013DHF/Control 20 (DHF) (23 ± 8 yr); 20 (control) (23 ± 5 yr) -ECG. ECHOLVEF reduced in DHF compared with controls (51.25 ± 0.96% vs 59.32 ± 1.26%; P = 0.032). DHF patients had: (1) Peak longitudinal strain in subendocardial region; (2) Circumferential strain in the subepicardial region; and (3) Radial strain
Yadav et al[33], 2013DHF/DSS67 (3 mo-14 yr)48 (ECHO); 70 (Tei index)ECG. ECHO. Cardiac markersLVEF showed 48% cardiac involvement. Tei index showed 70% cardiac involvement. Tei index improved on discharge but did not normalize
Kirawittaya et al[34], 2015DF/DHF/DSS 181 DF/DHF 35 Non-DF (< 15 yr) 14.50 ECG. ECHO. Cardiac markers DHF patients with plasma leakage had: (1) Cardiac index (2695 vs 3188 L/min/m2); (2) LV myocardial performance index (0.413 vs 0.328); (3) Systemic vascular resistance (2478 vs 1820 dynes.s/cm-5) compared to those without plasma leakage; and (4) Cardiac dysfunction was most pronounced around the time of plasma leakage
Li et al[35], 2016DHF/DSS1782 (adult)11.28ECG. ECHO. Cardiac markersNSD(WS+)/SD had 46.66% myocarditis. NSD(WS-) had 9.72% myocarditis. DHF with myocarditis had longer hospitalization. Prognosis of DHF patients with and without myocarditis had no significant difference
Bhatt et al[16], 2020DHF/DSS 182 (30.2 ± 12.6 yr) 7.10 ECG. ECHO. Cardiac markers ECG abnormality in 44/182 (24%). Cardiac markers’ elevation in 27/182 (14.83%). ECHO abnormality in 11/182 (6.04%)
Bhattacharjee et al[36], 2020DF84 (18-65 yr) (41 cases/43 controls)-ECG. ECHO. Cardiac markersCK, CK-MB, troponin T and NT-proBNP levels in cases were higher than in controls. Troponin T was positively correlated with NTproBNP
Cabrera-Rego et al[37], 2021DF/DHF/DSS 427 (> 18 yr) 19.70 ECG. ECHO Rhythm disorders in 16.9%. Repolarization disorders in 3.0%. Pericarditis in 1.6%. Pericardial effusion in 0.9%. Myocarditis in 0.2%
Shah et al[38], 2021DF320 (> 18 yr)35ECG. ECHO. Cardiac markersSinus bradycardia in 19.7%. LVEF < 40% in 13.1%. Elevated troponin T in 15%. Elevated CK-MB in 10.6%. Elevated NTproBNP in 5.9%. Mortality rate was 4.38% with cardiac involvement
Table 3 Primary histopathological features of cardiac involvement in autopsy of dengue hemorrhagic fever patients
Ref.
Autopsy cases, n
Gross findings
Histopathological findings
Bhamarapravati et al[15], 1967100 Focal areas of hemorrhage in the epicardium, sub endocardium, interstitial tissues, or combined Separation of myocardial fibers with the interstitial tissue edema. Extensive hemorrhage in myocardium with condensation and acidophilic pattern of myocardial fibrils
Burke[39], 196812 Petechial hemorrhage in epicardium, sub endocardium, and myocardium No evidence of myocarditis. Normal blood vessels
Weerakoon et al[20], 20115 Evidence of florid myocarditis Interstitial edema with inflammatory cell infiltration and necrosis of myocardial fibers. Evidence of pericarditis
Kularatne et al[40], 20183 Petechial hemorrhage Interstitial edema with infiltration of neutrophils and lymphocytes. Lymphocytic infiltration in endomyseum
Marques et al[41], 20131 NRAcute myocarditis with multiple areas of myocardial necrosis sur-rounded by inflammatory cellular infiltrate
Rathi et al[42], 20136 Hemorrhagic spots over pericardium, epicardium. Mild ventricular hypertrophy Lymphocytic myocarditis